HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Klagsbrun Selected Research

Neuropilins

1/2011Neuropilin-2 expression promotes TGF-β1-mediated epithelial to mesenchymal transition in colorectal cancer cells.
8/2010A mutated soluble neuropilin-2 B domain antagonizes vascular endothelial growth factor bioactivity and inhibits tumor progression.
3/2009Advanced glycation end-products suppress neuropilin-1 expression in podocytes.
4/2007Neuropilins: novel targets for anti-angiogenesis therapies.
3/2006Neuropilins in neoplasms: expression, regulation, and function.
3/2002Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis.
1/2002The role of neuropilin in vascular and tumor biology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Klagsbrun Research Topics

Disease

31Neoplasms (Cancer)
07/2015 - 01/2002
6Neoplasm Metastasis (Metastasis)
01/2013 - 11/2004
3Inflammation (Inflammations)
11/2016 - 01/2005
3Glioblastoma (Glioblastoma Multiforme)
05/2014 - 05/2011
3Melanoma (Melanoma, Malignant)
05/2011 - 08/2010
3Colonic Neoplasms (Colon Cancer)
01/2011 - 06/2004
2Hydrocephalus (Hydrocephaly)
01/2016 - 09/2013
2Hemangioma (Angioma)
08/2015 - 01/2015
2Medulloblastoma
07/2014 - 02/2013
2Brain Neoplasms (Brain Tumor)
01/2013 - 02/2012
2Hypoxia (Hypoxemia)
05/2011 - 07/2002
1Lymphedema (Milroy Disease)
11/2016
1Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
01/2016
1Carcinoma (Carcinomatosis)
08/2015
1Skin Neoplasms (Skin Cancer)
07/2015
1Pathologic Neovascularization
06/2013
1Neurilemmoma (Schwannoma)
02/2012
1Vascular Diseases (Vascular Disease)
12/2011
1Colorectal Neoplasms (Colorectal Cancer)
01/2011
1Aneuploidy (Aneuploid)
12/2009
1Diabetic Nephropathies (Diabetic Nephropathy)
03/2009
1Glioma (Gliomas)
10/2008
1Vascular Calcification
09/2008
1Cataract (Cataracts)
07/2006
1Edema (Dropsy)
01/2005
1Hypersensitivity (Allergy)
01/2005
1Nevus (Nevi)
11/2004
1Hyperplasia
11/2004

Drug/Important Bio-Agent (IBA)

12Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 03/2002
10Semaphorins (Semaphorin)IBA
08/2015 - 11/2004
7NeuropilinsIBA
01/2011 - 01/2002
6Neuropilin-2IBA
11/2016 - 11/2004
6Proteins (Proteins, Gene)FDA Link
07/2015 - 12/2007
4Messenger RNA (mRNA)IBA
07/2014 - 06/2004
4Phosphotransferases (Kinase)IBA
05/2014 - 02/2006
4Epidermal Growth Factor (EGF)IBA
05/2008 - 07/2002
4ErbB Receptors (EGF Receptor)IBA
05/2008 - 07/2002
3Netrin-1IBA
01/2016 - 01/2013
3Angiogenesis InhibitorsIBA
09/2013 - 11/2004
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2013 - 07/2002
3Neuropilin-1IBA
02/2013 - 03/2003
2Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
01/2016 - 07/2002
2neogeninIBA
01/2016 - 07/2014
2Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
08/2015 - 01/2015
2Semaphorin-3AIBA
05/2014 - 01/2002
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
02/2013 - 03/2002
2Actins (F Actin)IBA
05/2011 - 01/2008
2Transcription Factors (Transcription Factor)IBA
05/2010 - 01/2002
2AntibodiesIBA
12/2007 - 04/2007
2Mitogen-Activated Protein KinasesIBA
02/2006 - 06/2004
1GalactosidasesIBA
01/2016
1lysophosphatidylinositolIBA
08/2015
14- (4- (3- hydroxyphenyl)- 3- (4- methylphenyl)- 6- oxo- 1H,4H,5H,6H- pyrrolo(3,4- c)pyrazol- 5- yl)benzoic acidIBA
08/2015
1EndocannabinoidsIBA
08/2015
1Biomarkers (Surrogate Marker)IBA
07/2014
1Tyrosine Kinase InhibitorsIBA
05/2014
1Imatinib Mesylate (Gleevec)FDA Link
05/2014
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
09/2013
1matrigelIBA
01/2013
1Cysteine Proteases (Cysteine Protease)IBA
01/2013
1EnzymesIBA
01/2013
1Cathepsin BIBA
01/2013
1Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
01/2013
1Annexin A2 (Annexin II)IBA
01/2013
1Metalloproteases (Metalloproteinases)IBA
11/2012
1GTP Phosphohydrolases (GTPases)IBA
11/2012
1ADP-Ribosylation Factor 6IBA
11/2012
1RNA (Ribonucleic Acid)IBA
11/2012
1Caveolin 1IBA
11/2012
1Neurofibromin 2 (Merlin)IBA
02/2012
1Retinaldehyde (Retinal)IBA
12/2011
1Conditioned Culture MediaIBA
05/2011
1Deferoxamine (Desferal)FDA LinkGeneric
05/2011
1Keratin-20 (Cytokeratin 20)IBA
01/2011
1VimentinIBA
01/2011
1Cadherins (E-Cadherin)IBA
01/2011
1Matrix Metalloproteinases (MMPs)IBA
10/2010
1Bevacizumab (Avastin)FDA Link
08/2010
1plexinIBA
08/2010
1CD13 Antigens (Alanine Aminopeptidase)IBA
04/2010
1DNA ProbesIBA
12/2009
1Advanced Glycation End ProductsIBA
03/2009
1Actin Depolymerizing Factors (Cofilins)IBA
10/2008
1ARG tyrosine kinaseIBA
10/2008
1OsteopontinIBA
09/2008
1OsteocalcinIBA
09/2008
1Phenobarbital (Luminal)FDA Link
09/2008
1GelsIBA
08/2008
1Y 27632IBA
08/2008
1Gefitinib (Iressa)FDA Link
05/2008
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
05/2008
1Neutralizing AntibodiesIBA
12/2007
1gamma-CrystallinsIBA
07/2006
1Crystallins (Crystallin)IBA
07/2006
1LigandsIBA
08/2005
1CollagenIBA
11/2004
1Fibronectins (Fibronectin)IBA
11/2004

Therapy/Procedure

6Therapeutics
02/2013 - 02/2006
1Aftercare (After-Treatment)
05/2011
1Traction
08/2008